Avalyn Pharma Inc.
AVLN
14 insider filings · Latest: May 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 5 8:15 PM | Novo Holdings A/S10% Owner | Purchase | 555,555 | $18.00 | $10.0M | 3,883,289(D) | View → |
| May 1, 2026 | May 1 10:50 PM | Jill CarrollDirector | Purchase | 277,778 | $18.00 | $5.0M | 2,186,562(I) | View → |
| May 1, 2026 | May 1 10:46 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Purchase | 555,555 | $18.00 | $10.0M | 1,122,087(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 5 8:15 PM | Novo Holdings A/S10% Owner | Conversion | 64,031,337 | — | 0(D) | View → |
| May 1, 2026 | May 5 12:37 PM | FMR LLC10% Owner, Other | Conversion | 2,284,535 | — | 0(I) | View → |
| Apr 29, 2026 | May 4 10:01 AM | Adam H. GoldenGeneral Counsel | Grant/Award | 254,891 | $18.00 | 254,891(D) | View → |
| May 1, 2026 | May 1 10:50 PM | Jill CarrollDirector | Conversion | 36,728,280 | — | 0(I) | View → |
| May 1, 2026 | May 1 10:46 PM | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 52,974,269 | — | 0(I) | View → |
| Apr 29, 2026 | May 1 10:32 PM | Jon CongletonDirector | Grant/Award | 26,978 | $18.00 | 26,978(D) | View → |
| Apr 29, 2026 | May 1 10:29 PM | Heather D TurnerDirector | Grant/Award | 26,978 | $18.00 | 26,978(D) | View → |
| Apr 29, 2026 | May 1 10:28 PM | Melissa RhodesChief Operating Officer | Grant/Award | 211,975 | $18.00 | 211,975(D) | View → |
| Apr 30, 2026 | May 1 10:27 PM | Douglas R CarlsonChief Financial Officer | Grant/Award | 211,975 | $18.00 | 211,975(D) | View → |
| Apr 29, 2026 | May 1 10:27 PM | Kate HavilandDirector | Grant/Award | 26,978 | $18.00 | 26,978(D) | View → |
| May 1, 2026 | May 1 10:26 PM | Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10% Owner | Conversion | 24,542,548 | — | 0(D) | View → |
| Apr 29, 2026 | May 1 10:26 PM | Howard LazarusChief Medical Officer | Grant/Award | 211,975 | $18.00 | 211,975(D) | View → |
| Apr 30, 2026 | May 1 10:26 PM | Erin LavelleDirector | Grant/Award | 26,978 | $18.00 | 26,978(D) | View → |
| Apr 29, 2026 | May 1 10:25 PM | Lyn BaranowskiDirector, Chief Executive Officer | Grant/Award | 501,033 | $18.00 | 501,033(D) | View → |